Article
Sulfasalazine improves psoriasis. A double-blind analysis.
Archives of dermatology - 1 Apr 1990
Gupta A K, Ellis C N, Siegel M T, Duell E A, Griffiths C E, Hamilton T A, Nickoloff B J, Voorhees J J
Abstract excerpt
In an 8-week double-blind trial of sulfasalazine for the treatment of moderate-to-severe psoriasis, 23 and 27 patients received the active and placebo tablets, respectively. At the end of the double-blind phase, there were 17 assessable patients receiving sulfasalazine; 7 (41%) had marked improve...
Topics
- Adult
- Body Surface Area
- Clinical Trials as Topic
- Double-Blind Method
- Eicosanoids
- Female
- Humans
- Immunoenzyme Techniques
- Male
- Middle Aged
- Phenotype
- Placebos
- Psoriasis